Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220999373> ?p ?o ?g. }
- W4220999373 endingPage "656" @default.
- W4220999373 startingPage "656" @default.
- W4220999373 abstract "In the current research, a thymoquinone-enriched naringenin (NGN)-loaded nanostructured lipid carrier (NLC) was developed and delivered via the nasal route for depression. Thymoquinone (TQ) oil was used as the liquid lipid and provided synergistic effects. A TQ- and NGN-enriched NLC was developed via the ultrasonication technique and optimized using a central composite rotatable design (CCRD). The optimized NLC exhibited the following properties: droplet size, 84.17 to 86.71 nm; PDI, 0.258 to 0.271; zeta potential, -8.15 to -8.21 mV; and % EE, 87.58 to 88.21%. The in vitro drug release profile showed the supremacy of the TQ-NGN-NLC in comparison to the NGN suspension, with a cumulative drug release of 82.42 ± 1.88% from the NLC and 38.20 ± 0.82% from the drug suspension. Ex vivo permeation study displayed a 2.21-fold increase in nasal permeation of NGN from the NLC compared to the NGN suspension. DPPH study showed the better antioxidant potential of the TQ-NGN-NLC in comparison to NGN alone due to the synergistic effect of NGN and TQ oil. CLSM images revealed deeper permeation of the NGN-NLC (39.9 µm) through the nasal mucosa in comparison to the NGN suspension (20 µm). Pharmacodynamic studies, such as the forced swim test and the locomotor activity test, were assessed in the depressed rat model, which revealed the remarkable antidepressant effect of the TQ-NGN-NLC in comparison to the NGN suspension and the marketed formulation. The results signify the potential of the TQ-enriched NGN-NLC in enhancing brain delivery and the therapeutic effect of NGN for depression treatment." @default.
- W4220999373 created "2022-04-03" @default.
- W4220999373 creator A5011624381 @default.
- W4220999373 creator A5025737605 @default.
- W4220999373 creator A5028029863 @default.
- W4220999373 creator A5045114713 @default.
- W4220999373 creator A5049947030 @default.
- W4220999373 creator A5053306980 @default.
- W4220999373 creator A5060689301 @default.
- W4220999373 creator A5065753309 @default.
- W4220999373 creator A5068031055 @default.
- W4220999373 creator A5078079379 @default.
- W4220999373 date "2022-03-16" @default.
- W4220999373 modified "2023-10-16" @default.
- W4220999373 title "Thymoquinone-Enriched Naringenin-Loaded Nanostructured Lipid Carrier for Brain Delivery via Nasal Route: In Vitro Prospect and In Vivo Therapeutic Efficacy for the Treatment of Depression" @default.
- W4220999373 cites W1943534187 @default.
- W4220999373 cites W1964722139 @default.
- W4220999373 cites W1987688990 @default.
- W4220999373 cites W1988830468 @default.
- W4220999373 cites W1992535564 @default.
- W4220999373 cites W1994881743 @default.
- W4220999373 cites W1996830776 @default.
- W4220999373 cites W2026537351 @default.
- W4220999373 cites W2027762080 @default.
- W4220999373 cites W2040095473 @default.
- W4220999373 cites W2043442041 @default.
- W4220999373 cites W2058719755 @default.
- W4220999373 cites W2078145173 @default.
- W4220999373 cites W2083571917 @default.
- W4220999373 cites W2086776758 @default.
- W4220999373 cites W2087515552 @default.
- W4220999373 cites W2102024613 @default.
- W4220999373 cites W2131167630 @default.
- W4220999373 cites W2144783796 @default.
- W4220999373 cites W2154853392 @default.
- W4220999373 cites W2159200793 @default.
- W4220999373 cites W2219654308 @default.
- W4220999373 cites W2311082960 @default.
- W4220999373 cites W2405573244 @default.
- W4220999373 cites W2414998610 @default.
- W4220999373 cites W2486325144 @default.
- W4220999373 cites W2606695026 @default.
- W4220999373 cites W2771478918 @default.
- W4220999373 cites W2776562011 @default.
- W4220999373 cites W2778198757 @default.
- W4220999373 cites W2794041870 @default.
- W4220999373 cites W2806222039 @default.
- W4220999373 cites W2898588982 @default.
- W4220999373 cites W2901377967 @default.
- W4220999373 cites W2901682025 @default.
- W4220999373 cites W2908110420 @default.
- W4220999373 cites W2908708255 @default.
- W4220999373 cites W2938566593 @default.
- W4220999373 cites W2943168741 @default.
- W4220999373 cites W2943926418 @default.
- W4220999373 cites W2951686954 @default.
- W4220999373 cites W2967946137 @default.
- W4220999373 cites W2971406640 @default.
- W4220999373 cites W2971879604 @default.
- W4220999373 cites W2977804571 @default.
- W4220999373 cites W2991326441 @default.
- W4220999373 cites W3012929643 @default.
- W4220999373 cites W3024654823 @default.
- W4220999373 cites W3037874935 @default.
- W4220999373 cites W3043696061 @default.
- W4220999373 cites W3088014179 @default.
- W4220999373 cites W3088162600 @default.
- W4220999373 cites W3094650461 @default.
- W4220999373 cites W3111689237 @default.
- W4220999373 cites W3113735313 @default.
- W4220999373 cites W3120240564 @default.
- W4220999373 cites W3120241145 @default.
- W4220999373 cites W3127980075 @default.
- W4220999373 cites W3129769969 @default.
- W4220999373 cites W3166601301 @default.
- W4220999373 cites W3186211590 @default.
- W4220999373 cites W3194563175 @default.
- W4220999373 cites W3198492480 @default.
- W4220999373 cites W4200091878 @default.
- W4220999373 cites W4210640442 @default.
- W4220999373 doi "https://doi.org/10.3390/pharmaceutics14030656" @default.
- W4220999373 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35336030" @default.
- W4220999373 hasPublicationYear "2022" @default.
- W4220999373 type Work @default.
- W4220999373 citedByCount "12" @default.
- W4220999373 countsByYear W42209993732022 @default.
- W4220999373 countsByYear W42209993732023 @default.
- W4220999373 crossrefType "journal-article" @default.
- W4220999373 hasAuthorship W4220999373A5011624381 @default.
- W4220999373 hasAuthorship W4220999373A5025737605 @default.
- W4220999373 hasAuthorship W4220999373A5028029863 @default.
- W4220999373 hasAuthorship W4220999373A5045114713 @default.
- W4220999373 hasAuthorship W4220999373A5049947030 @default.
- W4220999373 hasAuthorship W4220999373A5053306980 @default.
- W4220999373 hasAuthorship W4220999373A5060689301 @default.
- W4220999373 hasAuthorship W4220999373A5065753309 @default.
- W4220999373 hasAuthorship W4220999373A5068031055 @default.
- W4220999373 hasAuthorship W4220999373A5078079379 @default.